Shareprice
01 Mar 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

ABG Sundal Collier initiates equity research on FluoGuide

News


November 19, 2021

 

Copenhagen, Denmark, 19 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the Swedish investment bank ABG Sundal Collier (ABG) has initiated equity research coverage on FluoGuide.

Starting today, ABG has initiated its equity research, meaning that ABG will continuously monitor and analyze FluoGuide’s operations, its products, markets, and competitors. The equity research is proprietary information only to ABG clients.